StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) stock

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Financials through Q3 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.42+0.02 (+0.31%)

Close on Nov 13, 2026Market cap $243.02MP/E –Yield –

Lifecore Biomedical gross margin

Gross margin is gross profit as a percentage of revenue.

Lifecore Biomedical's gross margin for the twelve months ending May 25, 2025 was 31.3%. For fiscal 2025 it was 31.3%, against 32.6% the year before. The highest annual figure on record is 38.6% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025May 25, 202531.3%−1.4
FY2024May 26, 202432.6%+5.5
FY2023May 28, 202327.1%−8.0
FY2022May 29, 202235.1%−3.5
FY2021May 30, 202138.6%+14.0
FY2020May 31, 202024.6%+10.1
FY2019May 26, 201914.5%−0.4
FY2018May 27, 201814.9%−1.9
FY2017May 28, 201716.9%+2.9
FY2016May 29, 201614.0%+1.9
FY2015May 31, 201512.1%−1.0
FY2014May 25, 201413.1%−1.1
FY2013May 26, 201314.2%−2.2
FY2012May 27, 201216.4%−0.5
FY2011May 29, 201116.9%+2.7
FY2010May 30, 201014.2%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2027CQ1 2026Sep 30, 202627.0%+5.2
Q4 FY2025CQ2 2025May 25, 202538.4%−7.2
Q3 FY2025CQ1 2025Feb 23, 202528.0%−5.3
Q2 FY2025CQ4 2024Nov 24, 202434.0%+1.0
Q1 FY2025CQ3 2024Aug 25, 202421.8%+10.7
Q4 FY2024CQ2 2024May 26, 202445.6%+20.6
Q3 FY2024CQ1 2024Feb 25, 202433.3%+1.1
Q2 FY2024CQ4 2023Nov 26, 202333.0%+7.1
Q1 FY2024CQ3 2023Aug 27, 202311.1%−14.1
Q4 FY2023CQ2 2023May 28, 202325.0%−12.1
Q3 FY2023CQ1 2023Feb 26, 202332.2%−0.8
Q2 FY2023CQ4 2022Nov 27, 202226.0%−18.8
Q1 FY2023CQ3 2022Aug 28, 202225.2%+0.4
Q4 FY2022CQ2 2022May 29, 202237.1%+4.6
Q3 FY2022CQ1 2022Feb 27, 202233.0%−6.3
Q2 FY2022CQ4 2021Nov 28, 202144.8%−0.5
Q1 FY2022CQ3 2021Aug 29, 202124.8%+1.5
Q4 FY2021CQ2 2021May 30, 202132.5%+17.0
Q3 FY2021CQ1 2021Feb 28, 202139.3%+26.2
Q2 FY2021CQ4 2020Nov 29, 202045.3%+34.4
Q1 FY2021CQ3 2020Aug 30, 202023.3%+12.3
Q4 FY2020CQ2 2020May 31, 202015.4%−1.7
Q3 FY2020CQ1 2020Feb 23, 202013.1%−0.8
Q2 FY2020CQ4 2019Nov 24, 201910.9%−2.7
Q1 FY2020CQ3 2019Aug 25, 201911.1%−2.0
Q4 FY2019CQ2 2019May 26, 201917.2%−0.4
Q3 FY2019CQ1 2019Feb 24, 201913.9%+0.2
Q2 FY2019CQ4 2018Nov 25, 201813.6%+1.4
Q1 FY2019CQ3 2018Aug 26, 201813.1%−3.1
Q4 FY2018CQ2 2018May 27, 201817.6%+1.8
Q3 FY2018CQ1 2018Feb 25, 201813.7%−4.0
Q2 FY2018CQ4 2017Nov 26, 201712.2%−3.3
Q1 FY2018CQ3 2017Aug 27, 201716.2%−2.2
Q4 FY2017CQ2 2017May 28, 201715.8%−1.1
Q3 FY2017CQ1 2017Feb 26, 201717.7%–
Q2 FY2017CQ4 2016Nov 27, 201615.5%–
Q1 FY2017CQ3 2016Aug 28, 201618.4%–
Q4 FY2016CQ2 2016May 29, 201616.8%–

More Lifecore Biomedical figures

See a number that looks wrong?